Tommaso Barba

Tommaso Barba is a PhD candidate at the Centre for Psychedelic Research, Imperial College London, supervised by Dr. David Erritzoe and Prof. David Nutt. His research currently centers on the brain effects of short-acting psychedelics such as DMT and 5-MeO-DMT, conducting the first neuroimaging trials of these compounds in laboratory settings with Dr Chris Timmermann.

Tommaso's interests include the impact of psychedelics and MDMA on couples' intimacy, advocating for their potential in improving couples' connection within therapeutic settings.

He also focuses on the role of psychedelics in treating depression and enhancing well-being. Tommaso has co-authored over ten scientific papers, including five as the first author, in journals such as The Lancet EClinical Medicine and Nature Scientific Reports. This work has been widely recognised and covered by prominent media outlets, including Forbes USA, The Times, The Telegraph, Rolling Stone, and CNN.

Additionally, Tommaso collaborates with universities and startups in Italy and the USA.